首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Study on Calceolarioside A Anti-Aβ25–35-Induced Damage in SH-SY5Y cells by Atomic Force Microscopy
Authors:Yujuan Chen  Kaige Qu  Ying Wang  Qinghan Zhang  Ying Xie  Zuobing Wang
Institution:1. School of Life Sciences, Changchun University of Science and Technology, Changchun, 130022 China;2. International Research Center for Nano Handling and Manufacturing of China, Changchun University of Science and Technology, Changchun, 130022 China

Ministry of Education Key Laboratory for Cross-Scale Micro and Nano Manufacturing, Changchun University of Science and Technology, Changchun, 130022 China;3. School of Life Sciences, Changchun University of Science and Technology, Changchun, 130022 China

Ministry of Education Key Laboratory for Cross-Scale Micro and Nano Manufacturing, Changchun University of Science and Technology, Changchun, 130022 China;4. International Research Center for Nano Handling and Manufacturing of China, Changchun University of Science and Technology, Changchun, 130022 China

Abstract:Calceolarioside A is a phenylethyl glycoside compound, originally isolated from the bark of Fraxinus mandshurica Rupr. In this work, the protective effect of Calceolarioside A on beta Amyloid protein induced toxicity in SH-SY5Y cells was studied. DPPH experiment, MTT assay, SEM, Atomic force microscopy and Colony formation were used to study the activity of Calceolarioside A. The results in this article show that the survival rate of the cells with Calceolarioside A (20–40 mg/mL) was significantly higher than that of the model cells without Calceolarioside A. Calceolarioside A could protect SH-SY5Y cells by improving some parameters in cells, such as the cell height, Young's modulus, adhesion and branch. In summary, Calceolarioside A can reduce Aβ25–35-induced damage in SH-SY5Y cells. It can be a potential medicine to treatment with AD.
Keywords:antioxidants  atomic force microscopy  Aβ25–35  calceolarioside A  SH-SY5Y cells
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号